Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
BMJ
    July 2024
  1. LAL N
    India: Doctors report surge in use of off label GLP-1 agonists among rich.
    BMJ. 2024;386:q1605.
    >> Share

  2. DYER C
    People with type 1 diabetes and disordered eating need joined-up care, says coroner after woman's death.
    BMJ. 2024;386:q1597.
    >> Share

  3. VANDERPANT N, Ward E, Farrell E, Theodoraki A, et al
    Insulin for people with type 2 diabetes mellitus.
    BMJ. 2024;386:e078015.
    >> Share

  4. WISE J
    Covid-19: Progression to clinical type 1 diabetes accelerated after infection, study suggests.
    BMJ. 2024;386:q1557.
    >> Share

  5. SETHI J
    Use of language in diabetes: what's in a name?
    BMJ. 2024;386:q1446.
    >> Share

    June 2024
  6. MAHASE E
    GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use.
    BMJ. 2024;385:q1448.
    >> Share

  7. FU EL, Wexler DJ, Cromer SJ, Bykov K, et al
    SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
    BMJ. 2024;385:e078483.
    >> Share

  8. DOBLE E, Farrow D
    We need to tackle the increasing mountain of wasted plastic and cardboard from diabetes technologies.
    BMJ. 2024;385:q1337.
    >> Share

  9. ZHANG J, Li Y
    Increasing prevalence of type 1 diabetes in older age may be a good sign.
    BMJ. 2024;385:q1322.
    >> Share

  10. YANG K, Yang X, Jin C, Ding S, et al
    Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study.
    BMJ. 2024;385:e078432.
    >> Share


  11. New advances in type 1 diabetes.
    BMJ. 2024;385:q1224.
    >> Share

    May 2024
  12. JENKINS AJ, Ogle GD, Scibilia R, Schwarz P, et al
    People who need insulin are particularly vulnerable in disasters and conflicts.
    BMJ. 2024;385:q1109.
    >> Share

  13. BIDULKA P, Lugo-Palacios DG, Carroll O, O'Neill S, et al
    Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
    BMJ. 2024;385:e077097.
    >> Share

    April 2024
  14. MAHASE E
    Diabetes UK defends partnership with Slimming World in face of criticism.
    BMJ. 2024;385:q962.
    >> Share

  15. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

  16. NOLAN T
    The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
    BMJ. 2024;385:q859.
    >> Share

  17. SETHI J
    Breaking free from the stigma of diabetes.
    BMJ. 2024;385:q890.
    >> Share

  18. BOKINNI Y
    Barbados is in the grip of a diabetic foot amputation crisis.
    BMJ. 2024;385:q350.
    >> Share

  19. PASTERNAK B, Wintzell V, Hviid A, Eliasson B, et al
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ. 2024;385:e078225.
    >> Share

    March 2024
  20. CHRISTIE B
    Charity calls for Scottish government to increase access to diabetes technology.
    BMJ. 2024;384:q755.
    >> Share

  21. MAHASE E
    Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
    BMJ. 2024;384:q744.
    >> Share

  22. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  23. TANNE JH
    FDA approves first over-the-counter blood glucose monitor for diabetes.
    BMJ. 2024;384:q611.
    >> Share

  24. TANNE JH
    US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
    BMJ. 2024;384:q569.
    >> Share

    February 2024
  25. LANE MM, Gamage E, Du S, Ashtree DN, et al
    Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
    BMJ. 2024;384:e077310.
    >> Share

  26. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    >> Share

  27. BHALA N
    Liver steatosis linked to type 2 diabetes outcomes.
    BMJ. 2024;384:q309.
    >> Share

    January 2024
  28. YAO H, Zhang A, Li D, Wu Y, et al
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ. 2024;384:e076410.
    >> Share

  29. SUBRAMANIAN S, Khan F, Hirsch IB
    New advances in type 1 diabetes.
    BMJ. 2024;384:e075681.
    >> Share

  30. IACOBUCCI G
    Artificial pancreases for type 1 diabetes: Better access is "watershed moment"-but delivery is key.
    BMJ. 2024;384:q102.
    >> Share

  31. IACOBUCCI G
    Fragmented care is failing people with type 1 diabetes related eating disorders, inquiry finds.
    BMJ. 2024;384:q178.
    >> Share

  32. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    >> Share

    December 2023
  33. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    >> Share

  34. COHEN D
    GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm.
    BMJ. 2023;383:2906.
    >> Share

  35. CHEN TK, Hoenig MP, Nitsch D, Grams ME, et al
    Advances in the management of chronic kidney disease.
    BMJ. 2023;383:e074216.
    >> Share

    November 2023
  36. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    >> Share

  37. IACOBUCCI G
    England's diabetes prevention programme has delivered causal benefits, study reports.
    BMJ. 2023;383:p2691.
    >> Share

  38. MAHASE E
    NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes.
    BMJ. 2023;383:p2619.
    >> Share

    October 2023
  39. KAR P
    Partha Kar: The time to tackle rising type 2 diabetes is T2DaY.
    BMJ. 2023;383:p2490.
    >> Share

  40. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    >> Share

  41. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    >> Share

    September 2023
  42. WILL EJ
    SGLT2 inhibitors: here we go again?
    BMJ. 2023;382:2172.
    >> Share


  43. Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    BMJ. 2023;382:p2072.
    >> Share

  44. FOU L, Agwu JC, Aswani N, Bakhai C, et al
    Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2023;382:p1686.
    >> Share

  45. MAHASE E
    Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes.
    BMJ. 2023;382:2074.
    >> Share

  46. IACOBUCCI G
    Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.
    BMJ. 2023;382:2019.
    >> Share

    July 2023
  47. BRAITHWAITE B
    Risk of diabetes with statins: comparing apples with oranges.
    BMJ. 2023;382:p1720.
    >> Share

  48. IACOBUCCI G
    UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages.
    BMJ. 2023;382:1693.
    >> Share

  49. HANNA F, Wu P, Heald A, Fryer A, et al
    Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome.
    BMJ. 2023;382:e071675.
    >> Share

    June 2023
  50. MAHASE E
    Tackling structural racism is crucial to ending global diabetes crisis, researchers say.
    BMJ. 2023;381:p1439.
    >> Share

  51. WISE J
    Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds.
    BMJ. 2023;381:p1306.
    >> Share

    May 2023
  52. GRAY M
    Preventing type 2 diabetes: public health campaigns should focus on living longer better.
    BMJ. 2023;381:p1139.
    >> Share

  53. MANSI IA, Sumithran P, Kinaan M
    Risk of diabetes with statins.
    BMJ. 2023;381:e071727.
    >> Share

  54. IACOBUCCI G
    Diabetes: Missed routine checks are causing premature deaths in England, charity warns.
    BMJ. 2023;381:1070.
    >> Share

  55. WHITE SL, Ayman G, Bakhai C, Hillier TA, et al
    Screening and diagnosis of gestational diabetes.
    BMJ. 2023;381:e071920.
    >> Share

    April 2023
  56. VALABHJI J, Kar P
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p910.
    >> Share


  57. Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p941.
    >> Share

  58. SAUL H, Deeney B, Imison C, Tesfaye S, et al
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ. 2023;381:p866.
    >> Share

  59. MA L, Hu Y, Alperet DJ, Liu G, et al
    Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study.
    BMJ. 2023;381:e073406.
    >> Share

  60. FOROUHI NG
    Beverages and health outcomes in adults with type 2 diabetes.
    BMJ. 2023;381:p841.
    >> Share

  61. LYU H, Zhao SS, Zhang L, Wei J, et al
    Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
    BMJ. 2023;381:e073435.
    >> Share

  62. WISE J
    Diabetes cases in UK reach all time high, charity warns.
    BMJ. 2023;381:p848.
    >> Share

  63. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    >> Share

    March 2023
  64. MCCARTNEY M
    Semaglutide: should the media slim down its enthusiasm?
    BMJ. 2023;380:p624.
    >> Share

  65. WISE J
    Novo Nordisk suspended from industry body over serious breaches.
    BMJ. 2023;380:p634.
    >> Share

    February 2023
  66. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    >> Share

    January 2023
  67. IACOBUCCI G
    Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    BMJ. 2023;380:p55.
    >> Share

    December 2022
  68. XIE J, Wang M, Long Z, Ning H, et al
    Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.
    BMJ. 2022;379:e072385.
    >> Share

    November 2022
  69. TAYLOR L
    Diabetes prevalence in Americas tripled in 30 years.
    BMJ. 2022;379:o2868.
    >> Share

  70. IACOBUCCI G
    Type 1 diabetes: US approves drug that can delay onset.
    BMJ. 2022;379:o2798.
    >> Share

  71. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    >> Share

    October 2022
  72. MULVIHILL C, Brooks A, Basudev N, Lincoln P, et al
    Continuous glucose monitoring for adults and children with diabetes: summary of updated NICE guidance.
    BMJ. 2022;379:o2418.
    >> Share

  73. HUANG C, Wei K, Lee PMY, Qin G, et al
    Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.
    BMJ. 2022;379:e072157.
    >> Share

  74. IKOMI AE
    It's time to widen the capture of gestational diabetes in the UK.
    BMJ. 2022;379:o2444.
    >> Share

  75. DENG Y, Polley EC, Wallach JD, Dhruva SS, et al
    Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    BMJ. 2022;379:e070717.
    >> Share

    September 2022
  76. MAHASE E
    Type 1 diabetes: Global prevalence is set to double by 2040, study estimates.
    BMJ. 2022;378:o2289.
    >> Share

  77. YANG J, Qian F, Chavarro JE, Ley SH, et al
    Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study.
    BMJ. 2022;378:e070312.
    >> Share

  78. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    >> Share

    August 2022
  79. MARSTON L
    The failed promise of the US's Inflation Reduction Act for patients with diabetes.
    BMJ. 2022;378:o2086.
    >> Share

  80. HUSSAIN Z
    NHS to rollout continuous glucose monitors for all patients with type 1 diabetes.
    BMJ. 2022;378:o1935.
    >> Share

    July 2022
  81. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    >> Share

    June 2022
  82. HE L, Wang J, Ping F, Yang N, et al
    Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
    BMJ. 2022;377:e068882.
    >> Share

  83. WISE J
    Type 2 diabetes: Charity warns of "perfect storm" putting more children at risk.
    BMJ. 2022;377:o1451.
    >> Share

  84. WISE J
    Diabetes drug results in substantial weight loss in people with obesity, study finds.
    BMJ. 2022;377:o1406.
    >> Share

    May 2022

  85. Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1326.
    >> Share

  86. YE W, Luo C, Huang J, Li C, et al
    Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
    BMJ. 2022;377:e067946.
    >> Share

  87. KAWAHARA T, Suzuki G, Mizuno S, Inazu T, et al
    Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.
    BMJ. 2022;377:e066222.
    >> Share

  88. CHRISTIDES T
    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1166.
    >> Share

  89. RUSSELL EL
    Managing type 1 diabetes: have faith in patients.
    BMJ. 2022;377:o1240.
    >> Share

  90. ARMSTRONG GRAY T, Hussain S, Gray M
    Empower young people with type 1 diabetes.
    BMJ. 2022;377:o1237.
    >> Share

  91. MORAN GM, Bakhai C, Song SH, Agwu JC, et al
    Type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2022;377:o775.
    >> Share

    April 2022

  92. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2022;377:o1080.
    >> Share

  93. SAUL H, Gursul D, Cassidy S, Sharpe D, et al
    Why don't children and young people engage with diabetes services?
    BMJ. 2022;377:o750.
    >> Share

  94. NG SM, Corbett T, Doble E, Brooks A, et al
    Managing the psychosocial impact of type 1 diabetes in young people.
    BMJ. 2022;377:e070530.
    >> Share

    March 2022
  95. IACOBUCCI G
    All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE.
    BMJ. 2022;376:o834.
    >> Share

  96. DYER C
    Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place.
    BMJ. 2022;376:o787.
    >> Share

  97. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    >> Share

    February 2022
  98. MAHASE E
    Type 1 diabetes drug was withdrawn because of a "commercial conflict of interest," charity argues.
    BMJ. 2022;376:o373.
    >> Share

  99. TANNE JH
    Diabetes kills 100 000 Americans for second year in a row.
    BMJ. 2022;376:o300.
    >> Share

    January 2022
  100. MAHMOOD A, Dar S, Dabhad A, Aksi B, et al
    Advising patients with existing conditions about fasting during Ramadan.
    BMJ. 2022;376:e063613.
    >> Share


  101. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o109.
    >> Share

  102. JAYEDI A, Soltani S, Motlagh SZ, Emadi A, et al
    Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2022;376:e067516.
    >> Share

  103. SLUGGETT JK, Rigby D
    Simplifying medications for people with type 2 diabetes.
    BMJ. 2022;376:n3158.
    >> Share

    December 2021
  104. GAHUNGU N, Trueick R, Coopes M, Gabbay E, et al
    Paroxysmal atrial fibrillation.
    BMJ. 2021;375:e058568.
    >> Share

  105. BESSER REJ, Ng SM, Robertson EJ
    Screening children for type 1 diabetes.
    BMJ. 2021;375:e067937.
    >> Share

    November 2021
  106. NOLAN T
    Tom Nolan's research reviews-26 November 2021.
    BMJ. 2021;375:n2938.
    >> Share

  107. AUBERT CE, Lega IC, Bourron O, Train AJ, et al
    When and how to deintensify type 2 diabetes care.
    BMJ. 2021;375:e066061.
    >> Share

    October 2021
  108. IACOBUCCI G
    One in 10 UK adults could have diabetes by 2030, warns charity.
    BMJ. 2021;375:n2453.
    >> Share

    September 2021
  109. SLIEKER RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, et al
    Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    BMJ. 2021;374:n2134.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016